bioAffinity Technologies, Inc. (BIAFW) stock
BIAFWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 4/3056% below fair value
$0.24+0.00 (0.00%)
Close on Oct 30, 2026Market cap $23.58MP/E –Yield –
bioAffinity Technologies price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
bioAffinity Technologies's price to sales ratio was 4.0× on Oct 19, 2026, against 4.5× a year earlier. Over the last 4 years it ranged from 4.0× to 136.3×, with a median of 19.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 4.0× | −5.0 |
| 2025 | Dec 31, 2025 | 9.1× | −10.4 |
| 2024 | Dec 31, 2024 | 19.5× | −3.1 |
| 2023 | Dec 29, 2023 | 22.5× | – |